Somerset Therapeutics Private Limited - Company Profile

It is a chemicals private limited company based in Bangalore, Karnataka, India, established in 1990.
1990 Bangalore, Karnataka, India Active
Last Updated:
About Somerset Therapeutics Private Limited

Somerset Therapeutics Private Limited, a active private limited company, was established on 23 August 1990 in Bangalore, Karnataka, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U85110KA1990PTC011166. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹31.60 Cr.

Formerly known as Recon Pharma Private Limited, Wint Ac Limited. It upholds a compliant status. Employing 620 professional, Its leadership includes Karupannan Poongudi Murali (Whole-Time Director), Ramasamy Anbarasi Thirumoorti (Director), Kannilakshmaniyer Krishnamachary Paranjyothi (Director). Past directors included Balasubramaniam Rajalakshmi Arun Eashwar, Kavitha Krishnamoorthy, Sunil Bhagwanrao Gundewar. It holds ₹30.00 Cr open charges and ₹58.06 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at 54/1 / 54/2, Boodihal Village, Nelamangala, Bangalore, Karnataka, 562123.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110KA1990PTC011166

  • Registration Number

    011166

  • Incorporation Date

    23 August 1990

  • Authorized Capital

    ₹50.00 Cr

  • Paid-Up Capital

    ₹31.60 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 50.00 Cr
  • Paid Up Capital ₹ 31.60 Cr
  • Company Age 35 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 30.00 Cr
  • Satisfied Charges ₹ 58.06 Cr
  • Revenue Growth **** 26.09%
  • Profit Growth **** -200.62%
  • Ebitda **** -34.56%
  • Net Worth -43.86%
  • Total Assets **** 54.17%
Company report

Somerset Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Somerset Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Somerset Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Karupannan Poongudi Murali Whole-Time Director 01 Jan 2021 Current
Ramasamy Anbarasi Thirumoorti Director 23 May 2018 Current
Kannilakshmaniyer Krishnamachary Paranjyothi Director 27 Jul 2017 Current
Mohanambal Paramasivam Gounder Director 27 Nov 2024 Current
Velusamy Jaiashokan Director 27 Nov 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 May 2018 Past
Pramod Abcsdd Director 11 Aug 2017 Past
Pramod Abcsdd Manager - Past
Pramod Abcsdd Director 22 Aug 2010 Past
Pramod Abcsdd Managing Director 29 May 2017 Past
Pramod Abcsdd Director 01 Feb 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Somerset Therapeutics.

Somerset Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.09% increase. The company also saw a substantial fall in profitability, with a 200.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 43.86%.

Somerset Therapeutics revenue growth over time
Somerset Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
26.09%
*******
*******
*******
*******
Revenue from Operations
*******
28.51%
*******
*******
*******
*******
Total Assets
*******
54.17%
*******
*******
*******
*******
Profit or Loss
*******
-200.62%
*******
*******
*******
*******
Net Worth
*******
-43.86%
*******
*******
*******
*******
EBITDA
*******
-34.56%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Somerset Therapeutics?

In 2024, Somerset Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹300,000,000.00

Satisfied Charges

₹580,600,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 30.00 Cr
Latest Charge Details
Date Lender Amount Status
01 Feb 2024 Hdfc Bank Limited ₹30.00 Cr Open
23 Feb 2022 State Bank Of India ₹10.00 Cr Satisfied
20 Apr 2015 State Bank Of India ₹10.00 Cr Satisfied
29 Mar 2010 State Bank Of India ₹17.96 Cr Satisfied
09 Apr 2007 Uco Bank ₹7.90 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Somerset Therapeutics?

Somerset Therapeutics has a workforce of 620 employees as of Sep 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Somerset Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Somerset Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Somerset Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Somerset Therapeutics Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Somerset Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.

  • Director Appointment

    Jinal Jain M was appointed as a Company Secretary was appointed as a Company Secretary on 28 Feb 2025 & has been associated with this company since 11 months 23 days . was recorded as a recent event.

  • Director Appointment

    Mohanambal Paramasivam Gounder was appointed as a Director was appointed as a Director on 27 Nov 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Velusamy Jaiashokan was appointed as a Director was appointed as a Director on 27 Nov 2024 & has been associated with this company since 1 year 2 months . was documented.

  • Charges

    The activity A charge registered on 23 Feb 2022 via Charge ID 100546665 with State Bank Of India was fully satisfied on 06 Feb 2024. was completed.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Somerset Therapeutics Private Limited?

The CIN of Somerset Therapeutics Private Limited is U85110KA1990PTC011166.

Where is Somerset Therapeutics Private Limited headquartered?

Somerset Therapeutics Private Limited is headquartered at 54/1 / 54/2, Boodihal Village, Nelamangala, Bangalore, Karnataka, 562123.

When was Somerset Therapeutics Private Limited incorporated?

Somerset Therapeutics Private Limited was incorporated on 23 August 1990.

Who are the current directors of Somerset Therapeutics Private Limited?

The current directors of Somerset Therapeutics Private Limited are

What is the primary industry of Somerset Therapeutics Private Limited?

The primary industry of Somerset Therapeutics Private Limited is Manufacturing.

Is Somerset Therapeutics Private Limited a listed company?

Somerset Therapeutics Private Limited is unlisted.

What is the capital structure of Somerset Therapeutics Private Limited?

The authorized capital of Somerset Therapeutics Private Limited is ₹50.00 Cr, and the paid-up capital is ₹31.60 Cr.

What is the compliance status of Somerset Therapeutics Private Limited?

The compliance status of Somerset Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available